Immune System Diseases

905 trials 381 recruiting

Filter these 905 trials by phase, country and sponsor.

Open in Search →

Momelotinib in VEXAS syndrome Recruiting

2024-519779-24-00 VEXAS (VACUOLES, E1 ENZYME, X-LINKED, AUTOINFLAMMATORY, 4 2025-11-25
Phase III clinical trial to evaluate the efficacy and safety of specific immunotherapy with mannanconjugated allergoids for the treatment of… Recruiting

2023-508548-23-00 Aetiological treatment of moderate-to-severe allergic r 5 2025-11-21
A Phase 2b Study to Assess the Efficacy and Safety of IMVT-1402 in Patients With Graves' Disease Recruiting

2025-521920-31-00 Graves’ Disease 4 2025-11-21
A DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED, MULTIPLE RISING DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMA… Recruiting

2025-522097-36-00 alopecia areata 3 2025-11-19
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of ANB033 Recruiting

2024-520409-38-00 Eosinophilic esophagitis (EoE) 1 2025-11-14
A Phase II, Open-Label, Single-Center, Single-Arm Pilot Study to Evaluate the Safety, Tolerability and Efficacy of Blinatumomab for Treatmen… Recruiting

2025-523061-22-00 Granulomatous Polyangiitis 4 2025-11-14
A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN) ( PREVAIL ) Recruiting

2024-519345-30-00 IgA nephropathy 5 2025-11-12
Pneumoccocal vaccine response in patients without a spleen, vaccinated before or after spleen removal. Recruiting

2024-515363-63-00 Asplenia 6 2025-11-07
A clinical study of tulisokibart in people with rheumatoid arthritis (MK-7240-014) Recruiting

2025-521745-25-00 Rheumatoid Arthritis 4 2025-11-06
Dose determination study of a mix of Dermatophagoides allergenic extracts (pteronyssinus and farinae) for immunotherapy treatment, administe… Recruiting

2025-521522-15-00 Allergic rhinitis/rhinoconjunctivitis caused by dust mi 4 2025-11-05
A SINGLE-ARM, OPEN-LABEL, PHASE I STUDY TO DETERMINE THE SAFETY, TOLERABILITY, AND PRELIMINARY EFFICACY OF OBE-CEL IN PARTICIPANTS WITH REFR… Recruiting

2024-519552-93-00 Refractory Progressive Multiple Sclerosis 3 2025-11-03
A Phase 3 Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Deucravacitinib (BMS-986165) in Adolescent Participants with Moder… Recruiting

2023-506296-97-00 Moderate to Severe Plaque Psoriasis 5 2025-10-28
The use of dupilumab in treatment of indolent systemic mastocytosis with skin involvement Recruiting

2023-509111-89-00 Systemic mastocytosis with a slow course and involvemen 5 2025-10-15
Reduced Immunosuppression for Older Adult Kidney Transplant Recipients: the RELEASE study. Recruiting

2025-520535-16-00 End-stage renal disease 6 2025-10-10
A study to learn how the study drug bimekizumab works and how safe it is in treating moderate to severe hidradenitis suppurativa in children… Recruiting

2023-505323-31-00 Hidradenitis Suppurativa 5 2025-10-09
A study to determine the efficacy, safety, and tolerability of tibulizumab in adults with hidradenitis suppurativa Recruiting

2024-519736-17-00 Hidradenitis Suppurativa 4 2025-10-03
A study to investigate the efficacy and safety of rilzabrutinib in adult participants with Graves’ disease Recruiting

2025-521023-75-00 Immune system diseases 4 2025-10-03
A dose-finding Phase I study of F8IL10 intra-articular treatment in Rheumatoid Arthritis Recruiting

2024-517896-19-00 Patients with Rheumatoid Arthritis (RA) who, despite tr 3 2025-09-29
Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368, a FAAH/MAGL Inhibitor, in Participants with Multiple Sclerosis Spasti… Recruiting

2024-517745-14-00 Multiple Sclerosis Spasticity 4 2025-09-24
Otevřená studie fáze III kontrolovaná suplementací vitaminu D3 a rozdíly mezi mladými dospělými a seniory Recruiting

2024-519747-15-00 Healthy population 5 2025-09-15
A Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants, Healthy Chinese and Japanese Participants, a… Recruiting

2024-514186-18-00 Systemic Lupus Erythematosus 1 2025-09-09
Efficacy and safety of repeated Rituximab infusions in patients with Active Systemic SClerosis and background medication, a one year randomi… Recruiting

2025-520483-17-01 Systemic sclerosis 6 2025-09-02
Model-informed precision dosing during infliximab rescue therapy for patients with steroid-refractory acute severe ulcerative colitis: an ex… Recruiting

2023-503509-12-00 Acute severe ulcerative colitis 6 2025-09-01
Long-term follow-up of patients previously treated with autologous T cells genetically modified with viral vectors. Recruiting

2024-511684-28-00 Potential malignancy in patients who received treatment 4 2025-09-01